buy medicine online indiamedicine onlineloading...

    Ambroxol + Levocetirizine + Paracetamol/Acetaminophen + Phenylephrine

    Information about Ambroxol + Levocetirizine + Paracetamol/Acetaminophen + Phenylephrine

    Ambroxol + levocetirizine + paracetamol/acetaminophen + phenylephrine uses

    Ambroxol+Levocetirizine+Paracetamol/Acetaminophen+Phenylephrine is used in the treatment of common cold symptoms.

    How ambroxol + levocetirizine + paracetamol/acetaminophen + phenylephrine works

    This is a combination of three medicines: Ambroxol, Levocetirizine, Paracetamol and Phenylephrine, which relieves common cold symptoms. Ambroxol is a mucolytic which thins and loosens mucus (phlegm), making it easier to cough out. Levocetirizine is an antiallergic which relieves allergy symptoms like runny nose, watery eyes and sneezing. Paracetamol is an analgesic (pain reliever) and antipyretic (fever reducer). It blocks the release of certain chemical messengers in the brain that are responsible for pain and fever. Phenylephrine is a decongestant which narrows the small blood vessels providing relief from congestion or stuffiness in the nose.

    Common side effects of ambroxol + levocetirizine + paracetamol/acetaminophen + phenylephrine

    Nausea, Vomiting, Dryness in mouth, Upset stomach, Headache, Fatigue, Sleepiness, Loss of appetite, Allergic reaction, Insomnia (difficulty in sleeping)
    Content Details
    author-image
    Written By
    Dr. Love Sharma
    PhD (Pharmacology), PGDPRA
    author-image
    Reviewed By
    Dr. Shilpa Garcha
    MD (Pharmacology), MBBS
    Last updated on:
    18 Feb 2020 | 05:22 PM (IST)
    editorial-image
    Want to know more?
    Read Our Editorial Policy

    Available Medicine for Ambroxol + Levocetirizine + Paracetamol/Acetaminophen + Phenylephrine

    Frequently asked questions for Ambroxol + Levocetirizine + Paracetamol/Acetaminophen + Phenylephrine

    Ambroxol + Levocetirizine + Paracetamol/Acetaminophen + Phenylephrine

    Q. What is Ambroxol+Levocetirizine+Paracetamol/Acetaminophen+Phenylephrine?

    Ambroxol+Levocetirizine+Paracetamol/Acetaminophen+Phenylephrine is the combination of Ambroxol, Levocetirizine, Paracetamol / Acetaminophen and Phenylephrine and is used in the treatment of common cold.

    Q. Can the use of Ambroxol+Levocetirizine+Paracetamol/Acetaminophen+Phenylephrine cause nausea and vomiting?

    Yes, the use of Ambroxol+Levocetirizine+Paracetamol/Acetaminophen+Phenylephrine can cause nausea and vomiting. Taking it with milk, food or with antacids can prevent nausea. Avoid taking fatty or fried foods along with this medication. In case of vomiting, drink plenty of water or other fluids by taking small frequent sips. Talk to your doctor if vomiting persists and you notice signs of dehydration, like dark colored and strong-smelling urine and a low frequency of urination. Do not take any other medicine without speaking to a doctor.

    Q. Can the use of Ambroxol+Levocetirizine+Paracetamol/Acetaminophen+Phenylephrine cause dizziness?

    Yes, the use of Ambroxol+Levocetirizine+Paracetamol/Acetaminophen+Phenylephrine can cause dizziness (feeling faint, weak, unsteady or lightheaded) in some patients. If you feel dizzy or lightheaded, it is better to rest for some time and resume once you feel better.

    Q. Are there any specific contraindications associated with the use of Ambroxol+Levocetirizine+Paracetamol/Acetaminophen+Phenylephrine?

    The use of Ambroxol+Levocetirizine+Paracetamol/Acetaminophen+Phenylephrine is considered to be harmful for patients with known allergy to any of the components or excipients of this medicine and in patients with gastric ulcers, liver or kidney problems.

    Q. What are the recommended storage conditions for Ambroxol+Levocetirizine+Paracetamol/Acetaminophen+Phenylephrine?

    Keep this medicine in the container or the pack it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children and other people.

    Content on this page was last updated on 18 February, 2020, by Dr. Varun Gupta (MD Pharmacology)